Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Macon, W.
Right arrow Articles by Cousar, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Macon, W.
Right arrow Articles by Cousar, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Natural killer-like T-cell lymphomas: aggressive lymphomas of T-large granular lymphocytes [see comments]

WR Macon, ME Williams, JP Greer, RD Hammer, AD Glick, RD Collins and JB Cousar

Department of Pathology, Vanderbilt University Medical Center, Nashville, TN, USA.

Natural killer (NK)-like T cells are major histocompatibility complex- unrestricted cytotoxic T cells that are surface CD3-positive, express NK-cell antigens, and rearrange their T-cell receptor. Most neoplasms arising from this T-cell subpopulation have been a chronic lymphoproliferative disease referred to as T-large granular lymphocyte (LGL) leukemia. Only 10 NK-like T-cell lymphomas have been described in detail previously; this study presents the clinicopathologic features of six others and distinguishes these lymphomas from T-LGL leukemia. All patients presented with B-symptoms and often had marked hepatosplenomegaly without significant peripheral lymphadenopathy. Four of the six patients were immunosuppressed. All had CD3, CD8, CD56- positive tumors, presumably of hepatosplenic (n = 3), intestinal (n = 1), pulmonary (n = 1), or nodal (n = 1) origin. Three patients had lymphomatous bone marrow infiltrates, and four had peripheral blood involvement by neoplastic large lymphocytes, some of which had a blastic appearance or resembled virocytes. Azurophilic granules, ultrastructurally corresponding to cytoplasmic dense core and/or double density granules, were seen in all cases. T-cell clonality was shown in five tumors by Southern blot analysis, and three had abnormal karyotypes. Two untreated patients died 20 days after presentation, and three patients who received combination chemotherapy died within 5 months of presentation. One patient remains in complete remission 22 months after treatment. These findings suggest NK-like T-cell lymphomas are aggressive, are clinicopathologically distinct from T-LGL leukemia, and should be in the differential diagnosis of extranodal T-cell lymphoproliferations, including those in immunosuppressed patients. Furthermore, the LGL morphology, phenotype, and tissue distribution of some NK-like T-cell lymphomas suggest they arise from thymic- independent T cells of the hepatic sinusoids and intestinal mucosa.

Volume 87, Issue 4, pp. 1474-1483, 02/15/1996
Copyright © 1996 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Veterinary PathologyHome page
P. Roccabianca, W. Vernau, M. Caniatti, and P. F. Moore
Feline Large Granular Lymphocyte (LGL) Lymphoma with Secondary Leukemia: Primary Intestinal Origin with Predominance of a CD3/CD8{alpha}{alpha} Phenotype
Veterinary Pathology, January 1, 2006; 43(1): 15 - 28.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
M. G. Rose and N. Berliner
T-Cell Large Granular Lymphocyte Leukemia and Related Disorders
Oncologist, June 1, 2004; 9(3): 247 - 258.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
J. P. Greer, M. C. Kinney, and T. P. Loughran Jr.
T Cell and NK Cell Lymphoproliferative Disorders
Hematology, January 1, 2001; 2001(1): 259 - 281.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Suzuki, Y. Kagami, K. Takeuchi, M. Kami, M. Okamoto, R. Ichinohasama, N. Mori, M. Kojima, T. Yoshino, H. Yamabe, et al.
Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T/null cell phenotype
Blood, November 1, 2000; 96(9): 2993 - 3000.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. Orfao, G. Schmitz, B. Brando, A. Ruiz-Arguelles, G. Basso, R. Braylan, G. Rothe, F. Lacombe, F. Lanza, S. Papa, et al.
Clinically Useful Information Provided by the Flow Cytometric Immunophenotyping of Hematological Malignancies: Current Status and Future Directions
Clin. Chem., October 1, 1999; 45(10): 1708 - 1717.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
E. Berti, D. Tomasini, M. H Vermeer, C. J. Meijer, E. Alessi, and R. Willemze
Primary Cutaneous CD8-Positive Epidermotropic Cytotoxic T Cell Lymphomas : A Distinct Clinicopathological Entity with an AggressiveClinical Behavior
Am. J. Pathol., August 1, 1999; 155(2): 483 - 492.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. Chott, W. Haedicke, I. Mosberger, M. Fodinger, K. Winkler, C. Mannhalter, and H.-K. Muller-Hermelink
Most CD56+ Intestinal Lymphomas Are CD8+CD5- T-Cell Lymphomas of Monomorphic Small to Medium Size Histology
Am. J. Pathol., November 1, 1998; 153(5): 1483 - 1490.
[Abstract] [Full Text] [PDF]


Home page
Veterinary PathologyHome page
J. Darbes, M. Majzoub, W. Breuer, and W. Hermanns
Large Granular Lymphocyte Leukemia/Lymphoma in Six Cats
Veterinary Pathology, September 1, 1998; 35(5): 370 - 379.
[Abstract] [PDF]


Home page
BloodHome page
R. Suzuki, K. Yamamoto, M. Seto, Y. Kagami, M. Ogura, Y. Yatabe, T. Suchi, Y. Kodera, Y. Morishima, T. Takahashi, et al.
CD7+ and CD56+ Myeloid/Natural Killer Cell Precursor Acute Leukemia: A Distinct Hematolymphoid Disease Entity
Blood, September 15, 1997; 90(6): 2417 - 2428.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. K.C. Chan, V.C. Sin, K.F. Wong, C.S. Ng, W. Y.W. Tsang, C.H. Chan, M.M.C. Cheung, and W.H. Lau
Nonnasal Lymphoma Expressing the Natural Killer Cell Marker CD56: A Clinicopathologic Study of 49 Cases of an Uncommon Aggressive Neoplasm
Blood, June 15, 1997; 89(12): 4501 - 4513.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. S. Larson, S. Manning, W. R. Macon, and C. Vnencak-Jones
Microsatellite Instability in Natural Killer Cell-Like T-Cell Lymphomas in Immunocompromised and Immunocompetent Individuals
Blood, February 1, 1997; 89(3): 1114 - 1114.
[Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1996 by American Society of Hematology         Online ISSN: 1528-0020